OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel therapeutic targets for cancer metastasis
Konstantin Stoletov, Perrin H. Beatty, John D. Lewis
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. 2, pp. 97-109
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review
Shikha Indoria, Vickramjeet Singh, Ming‐Fa Hsieh
International Journal of Pharmaceutics (2020) Vol. 582, pp. 119314-119314
Closed Access | Times Cited: 159

Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment
Маргарита Е. Неганова, Junqi Liu, Yulia Aleksandrova, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6062-6062
Open Access | Times Cited: 59

Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 39

Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading
Valeria Naponelli, Maria Teresa Rocchetti, Domenica Mangieri
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5569-5569
Open Access | Times Cited: 11

Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)
Lian‐Shun Feng, Wen‐Qi Su, Jin‐Bo Cheng, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35

Menthol: An underestimated anticancer agent
Yijia Zhao, Huafeng Pan, Wei Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19

A Snapshot of Selenium-enclosed Nanoparticles for the Management of Cancer
Rohitas Deshmukh, Rajesh Singh, Sandeep Sharma, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 11, pp. 841-858
Closed Access | Times Cited: 8

3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response
Anna Senrung, Sakshi Lalwani, Divya Janjua, et al.
In vitro models (2023) Vol. 2, Iss. 6, pp. 219-248
Open Access | Times Cited: 14

Is There One Key Step in the Metastatic Cascade?
Antoine M. Dujon, Jean‐Pascal Capp, Joel S. Brown, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3693-3693
Open Access | Times Cited: 32

Exosomal circRNAs: Emerging Players in Tumor Metastasis
Hao Zhou, Xiaoyun He, Yuxiang He, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30

A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
Yanling Zhang, Yan Ma, Youqin Zeng, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 22, pp. 1704-1704
Open Access | Times Cited: 27

Primary tumor–derived systemic nANGPTL4 inhibits metastasis
Corinne Hübers, Ashik Ahmed Abdul Pari, Denise Grieshober, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 19

Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill
Yingying Tian, Beibei Ma, Shangyue Yu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 169-180
Open Access | Times Cited: 12

Antineoplastic effects of icaritin: molecular mechanisms and applications
Piao Luo, Liyang Zhang, Guangqing Cheng, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access

Laminin α5: a key factor in tumor metastasis
meiqi dong, Na Zhang
Clinical & Experimental Metastasis (2025) Vol. 42, Iss. 3
Closed Access

Antimicrobial Peptide Brevinin-1RL1 from Frog Skin Secretion Induces Apoptosis and Necrosis of Tumor Cells
Xiaoman Ju, Dongmei Fan, Lingmei Kong, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 2059-2059
Open Access | Times Cited: 25

In vitro anticancer efficacy of a polyphenolic combination of Quercetin, Curcumin, and Berberine in triple negative breast cancer (TNBC) cells
Akanksha Kashyap, Sheikh Mohammad Umar, Arundhathi Dev J R, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 2, pp. 100265-100265
Open Access | Times Cited: 18

Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3

Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression
Waseem Raza, Abha Meena, Suaib Luqman
Molecular Carcinogenesis (2024) Vol. 63, Iss. 9, pp. 1627-1642
Closed Access | Times Cited: 3

Targeting Oncoimmune Drivers of Cancer Metastasis
Chie Kudo‐Saito, Yukinori Ozaki, Hiroshi Imazeki, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 554-554
Open Access | Times Cited: 21

Metastatic Dissemination: Role of Tumor-Derived Extracellular Vesicles and Their Use as Clinical Biomarkers
Ilaria Giusti, Giuseppina Poppa, Giulia Di Fazio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9590-9590
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top